Sg3 Management, LLC Clovis Oncology, Inc. Transaction History

Sg3 Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$4.82 - $7.72 $26,510 - $42,460	-5,500 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$5.69 - $9.69 $25,605 - $43,605	-4,500 Reduced 45.0%	5,500 $37,000
Q1 2020 May 12, 2020	BUY	$3.77 - $11.0 $37,700 - $110,000	10,000 New	10,000 $64,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.